These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9066662

  • 1. Hyperbaric oxygen enhances the effects of meta-iodobenzylguanidine (MIBG) on energy metabolism and lipid peroxidation in the human neuroblastoma cell line SK-N-BE(2C).
    Cornelissen J, Van Kuilenburg AB, Elzinga L, Van der Kleij AD, Voûte PA, Van Gennip AH.
    Anticancer Res; 1997; 17(1A):259-64. PubMed ID: 9066662
    [Abstract] [Full Text] [Related]

  • 2. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines.
    Tytgat GA, Cornelissen J, Van den Brug M, Van Kuilenburg AB, Voute PA, Van der Kleij AJ, Van Gennip AH.
    Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473
    [Abstract] [Full Text] [Related]

  • 3. Meta-iodobenzylguanidine (MIBG) inhibits malate and succinate driven mitochondrial ATP synthesis in the human neuroblastoma cell line SK-N-BE(2c).
    Cornelissen J, Wanders RJ, Van den Bogert C, Van Kuilenburg AB, Elzinga L, Voûte PA, Van Gennip AH.
    Eur J Cancer; 1995; 31A(4):582-6. PubMed ID: 7576973
    [Abstract] [Full Text] [Related]

  • 4. MIBG causes oxidative stress and up-regulation of anti-oxidant enzymes in the human neuroblastoma cell line SK-N-BE(2c).
    Cornelissen J, Van Kuilenburg AB, Voûte PA, Van Gennip AH.
    Int J Cancer; 1997 Jul 29; 72(3):486-90. PubMed ID: 9247293
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
    Bruchelt G, Girgert R, Buck J, Wolburg H, Niethammer D, Treuner J.
    Cancer Res; 1988 Jun 01; 48(11):2993-7. PubMed ID: 3365688
    [Abstract] [Full Text] [Related]

  • 6. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J, Kavan P, Krízová H, Hermanská E, Dosel P, Sázel M.
    Cas Lek Cesk; 2001 Jan 19; 140(1):13-7. PubMed ID: 11242978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
    Montaldo PG, Carbone R, Lanciotti M, Ponzoni M, Cornaglia-Ferraris P.
    J Nucl Biol Med (1991); 1991 Jan 19; 35(4):195-8. PubMed ID: 1823817
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
    Iavarone A, Lasorella A, Servidei T, Riccardi R, Mastrangelo R.
    Cancer Res; 1993 Jan 15; 53(2):304-9. PubMed ID: 8417824
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
    Gaze MN, Hamilton TG, Mairs RJ.
    Br J Radiol; 1994 Jun 15; 67(798):573-8. PubMed ID: 8032811
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.